USANA Health Sciences, Inc. USNA
Set alert
14.31 USD -0.03 -0.21%
At close · Oct 30
14.31 0.00 0.00%
After hours · Oct 30, 4:01 PM ET
14.18 Day range 14.45
12.86 52-week range 23.24
- YTD
- -27.10%
- 1 year
- -27.51%
- Open
- 14.27
- Prev close
- 14.34
- Mkt cap
- 264.40M
- Vol
- 141.02K
- Avg vol
- 209.85K
- EPS
- -1.20
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 14.18
- High
- 14.45
- Forward P/E
- 13.69
- Beta
- 0.89
- Short ratio
- 5.95
- Inst. own
- 57.64%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 4, 2025
- 50-d avg
- 37.85
- 200-d avg
- 42.19
- 1y target
- 46.50
2Y chart
Events in this range
- Feb 4, 2025Earnings: —; estimate 0.49; surprise —%
Signals (97)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 29, 2026 | 2 days ago |
| SMA: Bullish | Oct 28, 2026 | 3 days ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 12, 2026 | 2 weeks ago |
| MACD: Buy Signal | Aug 26, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| RSI: Oversold | Aug 5, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 21, 2026 | 3 months ago |
| RSI: Overbought | Jul 7, 2026 | 3 months ago |
| RSI: Overbought | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | Jun 26, 2026 | 4 months ago |
| SMA: Bullish | Jun 18, 2026 | 4 months ago |
| SMA: Bearish | Jun 17, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 8, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 3, 2026 | 5 months ago |
| SMA: Bearish | May 29, 2026 | 5 months ago |
| SMA: Bullish | May 27, 2026 | 5 months ago |
| SMA: Bearish | May 26, 2026 | 5 months ago |
| MACD: Buy Signal | May 26, 2026 | 5 months ago |
| SMA: Bullish | May 21, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| MACD: Sell Signal | May 8, 2026 | 5 months ago |
| MACD: Buy Signal | May 6, 2026 | 5 months ago |
| SMA: Bullish | May 5, 2026 | 5 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| MACD: Sell Signal | May 4, 2026 | 6 months ago |
| RSI: Overbought | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 16, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 26, 2026 | 7 months ago |
| RSI: Oversold | Mar 12, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| MACD: Sell Signal | Mar 2, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 24, 2026 | 8 months ago |
| SMA: Bullish | Feb 20, 2026 | 8 months ago |
| SMA: Bearish | Feb 18, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 2, 2026 | 9 months ago |
| RSI: Overbought | Jan 21, 2026 | 9 months ago |
| SMA: Bullish | Jan 8, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 8, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 31, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 30, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 29, 2025 | 10 months ago |
| SMA: Bearish | Dec 26, 2025 | 10 months ago |
| SMA: Bullish | Dec 24, 2025 | 10 months ago |
| SMA: Bearish | Dec 19, 2025 | 10 months ago |
| SMA: Bullish | Dec 17, 2025 | 10 months ago |
| RSI: Oversold | Nov 18, 2025 | 11 months ago |
| RSI: Oversold | Nov 6, 2025 | 11 months ago |
| MACD: Buy Signal | Oct 28, 2025 | 1 year ago |
| RSI: Oversold | Oct 6, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 9, 2025 | 1 year ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
| SMA: Bullish | Aug 29, 2025 | 1 year ago |
| SMA: Bearish | Aug 28, 2025 | 1 year ago |
| SMA: Bullish | Aug 27, 2025 | 1 year ago |
| SMA: Bearish | Aug 26, 2025 | 1 year ago |
| SMA: Bullish | Aug 22, 2025 | 1 year ago |
| SMA: Bullish | Aug 22, 2025 | 1 year ago |
| SMA: Bearish | Aug 21, 2025 | 1 year ago |
| SMA: Bullish | Aug 19, 2025 | 1 year ago |
| SMA: Bearish | Aug 14, 2025 | 1 year ago |
| SMA: Bullish | Aug 13, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 13, 2025 | 1 year ago |
| SMA: Bearish | Jul 29, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 25, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 23, 2025 | 1 year ago |
| RSI: Overbought | Jul 23, 2025 | 1 year ago |
| SMA: Bullish | Jul 22, 2025 | 1 year ago |
| SMA: Bearish | Jul 18, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 15, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 1, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 30, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 25, 2025 | 1 year ago |
| MACD: Sell Signal | May 28, 2025 | 1 year ago |
| SMA: Bullish | Apr 30, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 22, 2025 | 1 year ago |
| RSI: Oversold | Apr 16, 2025 | 1 year ago |
| RSI: Oversold | Apr 7, 2025 | 1 year ago |
| RSI: Oversold | Mar 25, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 17, 2025 | 1 year ago |
| SMA: Bearish | Mar 12, 2025 | 1 year ago |
| SMA: Bullish | Mar 10, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 6, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 28, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 18, 2025 | 1 year ago |
| RSI: Oversold | Feb 12, 2025 | 1 year ago |
| RSI: Oversold | Feb 5, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 3, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 21, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 10, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 31, 2024 | 1 year ago |
Key statistics
- Market cap
- 646.88M
- Enterprise value
- 271.32M
- Trailing P/E
- 11.99
- Forward P/E
- 13.69
- PEG ratio
- 0.00
- Price / sales
- 0.75
- Price / book
- 1.21
- EPS (TTM)
- 2.83
- Beta
- 0.89
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 6.30%
- Revenue (TTM)
- 861.97M
- Revenue growth
- -6.20%
- Free cash flow
- 71.15M
- Total cash
- 364.89M
- Total debt
- 0
- Return on equity
- 10.83%
- Shares outstanding
- 19.06M
- Short % of float
- 4.42%
- 50-day average
- 37.85
- 200-day average
- 42.19
Analyst view
Consensus: none
Price target (mean) 46.50 +224.9% upside
Now 14.31
- Target (low)
- 35.00
- Target (mean)
- 46.50
- Target (high)
- 58.00
Ratings (0m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Feb 4, 2025
Expected Feb 4, 2025. Consensus EPS estimate 0.49.
Financials — quick view
USNA Revenue — quarterly 223.27M
USNA Net income — quarterly -21.38M
USNA EPS — quarterly -1.16
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 4, 2025 | Dec 1, 2024 | 0.49 | — | — | — |
| Oct 22, 2024 | Sep 1, 2024 | 0.49 | 0.56 | +0.07 | +14.29% |
| Jul 23, 2024 | Jun 1, 2024 | 0.65 | 0.54 | -0.11 | -16.92% |
| Apr 30, 2024 | Mar 1, 2024 | 0.69 | 0.86 | +0.17 | +24.64% |
| Feb 6, 2024 | Dec 1, 2023 | 0.52 | 0.87 | +0.35 | +67.31% |
| Oct 24, 2023 | Sep 1, 2023 | 0.64 | 0.59 | -0.05 | -7.81% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 23, 2024 | DA Davidson | main | Neutral | Neutral |
| Jul 25, 2024 | DA Davidson | main | Neutral | Neutral |
| May 7, 2024 | DA Davidson | main | Neutral | Neutral |
| Feb 22, 2024 | DA Davidson | main | Neutral | Neutral |
| Oct 25, 2023 | DA Davidson | main | Neutral | Neutral |
| Apr 26, 2023 | DA Davidson | main | — | Neutral |
About USANA Health Sciences, Inc.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Country
- United States
- Website
- usana.com
News
- USANA Schedules Third Quarter 2026 Earnings Release and Conference Call
- USANA Health Sciences and University of Utah Athletics Announce New Partnership
- USANA CEO Kevin Guest Shares Three Ways to Celebrate International Music Day
- Implied Volatility Surging for USANA Health Stock Options
- Protein Pop Launches Protein Pop Balance, a Clear Prebiotic Soda with 15 Grams of Protein and 5 Grams of Fiber
- USANA CEO Kevin Guest Calls on People to Find a Way to Serve Others, Then Act
- 12 Consumer Staples Stocks Moving In Thursday's After-Market Session
- USANA Introduces 3-in-1 Protein, Creatine, and Electrolyte Drink Mix
- Why Usana Health Sciences Stock Plummeted This Week
- USANA Health Sciences Q2 Earnings Call Highlights
Your note
Sign in to keep a note on USNA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROWN JIM H | Chief Executive Officer | Conversion of Exercise of derivative security | Jul 23, 2024 | 8,707 |
| DING XIA | Director | Conversion of Exercise of derivative security | Oct 31, 2024 | 3,534 |
| FLEMING JOHN TURMAN | Director | Conversion of Exercise of derivative security | Oct 31, 2024 | 3,852 |
| FULLER GILBERT A | Director | Sale | Nov 3, 2024 | 0 |
| JONES PAUL A | Officer | Sale | Aug 12, 2024 | 0 |
| NIXON J SCOTT | Director | Conversion of Exercise of derivative security | Oct 31, 2024 | 4,235 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 9.50% | 1,809,932 | 61.43M | Sep 29, 2024 |
| Vanguard Group Inc | 8.41% | 1,602,485 | 54.39M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 6.03% | 1,149,264 | 39.01M | Sep 29, 2024 |
| Pzena Investment Management Llc | 5.51% | 1,049,610 | 35.62M | Sep 29, 2024 |
| Dimensional Fund Advisors LP | 3.77% | 718,169 | 24.37M | Sep 29, 2024 |
| Pacer Advisors, Inc. | 2.86% | 544,256 | 18.47M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Core S&P Smallcap ETF | 3.70% | 705,335 | 23.94M | Oct 30, 2024 |
| Pacer Small Cap U.S. Cash Cows 100 ETF | 2.43% | 463,397 | 15.73M | Jul 30, 2024 |
| Vanguard Total Stock Market Index Fund | 1.88% | 358,868 | 12.18M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.52% | 289,321 | 9.82M | Oct 30, 2024 |
| Vanguard Small-Cap Index Fund | 1.50% | 286,497 | 9.72M | Sep 29, 2024 |
| Vanguard Small Cap Value Index Fund | 1.02% | 193,725 | 6.58M | Sep 29, 2024 |